Stay updated on MAGE-A1 TCR T-cells + Atezolizumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the MAGE-A1 TCR T-cells + Atezolizumab in Solid Tumors Clinical Trial page.

Latest updates to the MAGE-A1 TCR T-cells + Atezolizumab in Solid Tumors Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference11%

- Check34 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.3%

- Check49 days agoChange DetectedVersion bumped from v3.0.1 to v3.0.2. The 'Back to Top' element was removed, indicating a minor UI cleanup.SummaryDifference0.7%

- Check56 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.7%

- Check63 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location details, while several location-related terms have been removed.SummaryDifference20%

- Check77 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.3%

Stay in the know with updates to MAGE-A1 TCR T-cells + Atezolizumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MAGE-A1 TCR T-cells + Atezolizumab in Solid Tumors Clinical Trial page.